SEC Form 4 · accession 0001209191-17-001074
HARVARD BIOSCIENCE INC · HBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bertrand Loy
Director
Period of report
Jan 3, 2017
Accepted (ET)
Jan 4, 2017 · 4:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001123494
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 3, 2017 | A | 17,600 | $0.00 | A | 70,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes (a) a deferred stock award of 17,600 restricted stock units which vest quarterly in equal installments on March 31, 2017, June 30, 2017, September 30, 2017 and December 31, 2017; (b) a deferred stock award of 25,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after July 1, 2016, immediately prior to the commencement of such meeting, and (ii) July 1, 2017; and (c) 27,600 shares of common stock held by the Reporting Person.
Remarks
This form has been signed under power of attorney.